Role of cerebral blood flow in extreme breath holding
The role of cerebral blood flow (CBF) on a maximal breath-hold (BH) in ultra-elite divers was examined. Divers (n = 7) performed one control BH, and one BH following oral administration of the non-selective cyclooxygenase inhibitor indomethacin (1.2 mg/kg). Arterial blood gases and CBF were measured...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/296363fd70bd484d8cc61d0c4ef821df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:296363fd70bd484d8cc61d0c4ef821df |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:296363fd70bd484d8cc61d0c4ef821df2021-12-05T14:11:04ZRole of cerebral blood flow in extreme breath holding2081-693610.1515/tnsci-2016-0003https://doaj.org/article/296363fd70bd484d8cc61d0c4ef821df2016-01-01T00:00:00Zhttps://doi.org/10.1515/tnsci-2016-0003https://doaj.org/toc/2081-6936The role of cerebral blood flow (CBF) on a maximal breath-hold (BH) in ultra-elite divers was examined. Divers (n = 7) performed one control BH, and one BH following oral administration of the non-selective cyclooxygenase inhibitor indomethacin (1.2 mg/kg). Arterial blood gases and CBF were measured prior to (baseline), and at BH termination. Compared to control, indomethacin reduced baseline CBF and cerebral delivery of oxygen (CDO2) by about 26% (p < 0.01). Indomethacin reduced maximal BH time from 339 ± 51 to 319 ± 57 seconds (p = 0.04). In both conditions, the CDO2 remained unchanged from baseline to the termination of apnea. At BH termination, arterial oxygen tension was higher following oral administration of indomethacin compared to control (4.05 ± 0.45 vs. 3.44 ± 0.32 kPa). The absolute increase in CBF from baseline to the termination of apnea was lower with indomethacin (p = 0.01). These findings indicate that the impact of CBF on maximal BH time is likely attributable to its influence on cerebral H+ washout, and therefore central chemoreceptive drive to breathe, rather than to CDO2.Bain Anthony R.Ainslie Philip N.Hoiland Ryan L.Willie Chris K.MacLeod David B.Madden DennisMaslov Petra ZubinDrviš IvanDujić ŽeljkoDe Gruyterarticleapneacerebral oxygen deliveryhypercapniahypoxiaindomethacinNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENTranslational Neuroscience, Vol 7, Iss 1, Pp 12-16 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
apnea cerebral oxygen delivery hypercapnia hypoxia indomethacin Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 |
spellingShingle |
apnea cerebral oxygen delivery hypercapnia hypoxia indomethacin Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Bain Anthony R. Ainslie Philip N. Hoiland Ryan L. Willie Chris K. MacLeod David B. Madden Dennis Maslov Petra Zubin Drviš Ivan Dujić Željko Role of cerebral blood flow in extreme breath holding |
description |
The role of cerebral blood flow (CBF) on a maximal breath-hold (BH) in ultra-elite divers was examined. Divers (n = 7) performed one control BH, and one BH following oral administration of the non-selective cyclooxygenase inhibitor indomethacin (1.2 mg/kg). Arterial blood gases and CBF were measured prior to (baseline), and at BH termination. Compared to control, indomethacin reduced baseline CBF and cerebral delivery of oxygen (CDO2) by about 26% (p < 0.01). Indomethacin reduced maximal BH time from 339 ± 51 to 319 ± 57 seconds (p = 0.04). In both conditions, the CDO2 remained unchanged from baseline to the termination of apnea. At BH termination, arterial oxygen tension was higher following oral administration of indomethacin compared to control (4.05 ± 0.45 vs. 3.44 ± 0.32 kPa). The absolute increase in CBF from baseline to the termination of apnea was lower with indomethacin (p = 0.01). These findings indicate that the impact of CBF on maximal BH time is likely attributable to its influence on cerebral H+ washout, and therefore central chemoreceptive drive to breathe, rather than to CDO2. |
format |
article |
author |
Bain Anthony R. Ainslie Philip N. Hoiland Ryan L. Willie Chris K. MacLeod David B. Madden Dennis Maslov Petra Zubin Drviš Ivan Dujić Željko |
author_facet |
Bain Anthony R. Ainslie Philip N. Hoiland Ryan L. Willie Chris K. MacLeod David B. Madden Dennis Maslov Petra Zubin Drviš Ivan Dujić Željko |
author_sort |
Bain Anthony R. |
title |
Role of cerebral blood flow in extreme breath holding |
title_short |
Role of cerebral blood flow in extreme breath holding |
title_full |
Role of cerebral blood flow in extreme breath holding |
title_fullStr |
Role of cerebral blood flow in extreme breath holding |
title_full_unstemmed |
Role of cerebral blood flow in extreme breath holding |
title_sort |
role of cerebral blood flow in extreme breath holding |
publisher |
De Gruyter |
publishDate |
2016 |
url |
https://doaj.org/article/296363fd70bd484d8cc61d0c4ef821df |
work_keys_str_mv |
AT bainanthonyr roleofcerebralbloodflowinextremebreathholding AT ainsliephilipn roleofcerebralbloodflowinextremebreathholding AT hoilandryanl roleofcerebralbloodflowinextremebreathholding AT williechrisk roleofcerebralbloodflowinextremebreathholding AT macleoddavidb roleofcerebralbloodflowinextremebreathholding AT maddendennis roleofcerebralbloodflowinextremebreathholding AT maslovpetrazubin roleofcerebralbloodflowinextremebreathholding AT drvisivan roleofcerebralbloodflowinextremebreathholding AT dujiczeljko roleofcerebralbloodflowinextremebreathholding |
_version_ |
1718371410731073536 |